Lenalinomide plus rituximab for elderly patients with DLBCL, platelet GP6-mediated neutrophil recruitment in acute lung injury, and the role of AXL3 in mantle cell lymphoma.

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NHL Metropolitan Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 11PM EDT 5 min · 25 Sep 2026 · NPR News Now

We're Going Back To Mortis? 'Ahsoka' Season 2 Details Revealed! | The SWU Podcast LIVE 1h 39m · 25 Sep 2026 · The Star Wars Underworld Podcast

Microsoft AI Boss: “A Silicon Species” Could Compete With HumansMicrosoft AI Boss: “A Silicon Species” Could Compete With Humans 38 min · 25 Sep 2026 · AI Haven't A Clue

Who are the "passport bros" travelling abroad to find love? 5 min · 25 Sep 2026 · Do you really know?

Can plate colour really affect our sense of taste? 5 min · 25 Sep 2026 · Do you really know?

Report any issue

Source

Recorded26 Oct 2023

Publisherfeeds.transistor.fm ↗

Handlerec:11742000

Show notes

In this week's episode, we discuss the findings from a phase 2 study of lenalinomide plus rituximab in elderly frail patients with DLBCL, learn more about platelet GP6-mediated neutrophil recruitment in early stages of acute lung injury, and discuss a newly identified isoform of the tyrosine kinase AXL, termed AXL3, in mantle cell lymphoma.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in